ARCHIVES

Glaxo, Mass General Begin Phase III Trial Of Tykerb

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

April 3, 1998

Arnold Levine Named Professor At UMDNJ

February 28, 2003

In Brief: Appelbaum Clinical Dib. At Hutchinson; Vogelstein Win Pezcoller Award; Curiel To UAB

July 23, 1993

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997

IOM Calls For Rapid Reform Of Health Case System.

March 9, 2001

HCFA Sees Applications For DRGs And Research

September 27, 1985